KORU Medical Systems, Inc. (KRMD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 14.66K | 1.09M | 65.46K | -460.34K | -237.47K | 939.62K | -923.95K | 11.34K | -346.72K | 1.1M | -1.17M | -153.94K |
| Operating CF Margin % | 0.12% | 10.05% | 0.63% | -4.52% | -2.46% | 10.63% | -11.3% | 0.13% | -4.23% | 15.26% | -16.78% | -2.22% |
| Operating CF Growth % | 106.17% | 16.51% | 107.08% | -4161.23% | 31.51% | -14.33% | 21.36% | 107.36% | 92.56% | -17.93% | 44.47% | 94.64% |
| Net Income | -807.08K | -486.86K | -777.97K | -206.87K | -1.17M | -1.56M | -1.58M | -988.72K | -1.94M | -7.47M | -1.37M | -2.5M |
| Depreciation & Amortization | 197.53K | 179.17K | 204.48K | 209.49K | 217.36K | 211.45K | 227.79K | 217.86K | 231.37K | 228.34K | 216.01K | 212.92K |
| Stock-Based Compensation | 0 | 972.81K | 0 | 329.9K | 697.59K | 699.79K | 609.75K | 614.67K | 699.72K | 389.26K | 697.66K | 800.73K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -600K |
| Other Non-Cash Items | 680.53K | -104.54K | 627.39K | -833.2K | 363.61K | -4.84K | 329.37K | -183.99K | -5.2K | 5.47M | -931.23K | -5.5K |
| Working Capital Changes | -56.32K | 534.17K | 11.55K | 40.34K | -349.79K | 1.59M | -510.03K | 351.51K | 663.35K | 2.48M | 210.98K | 1.93M |
| Change in Receivables | 227.41K | -797.95K | -482.93K | 1.02M | -228.66K | -556.05K | 681.38K | -1.19M | -607.13K | -153.35K | -93.39K | 408.4K |
| Change in Inventory | -798.17K | 733.58K | -463.87K | -669.2K | -474.98K | 1.12M | -1.34M | 558.56K | 333.99K | 1.2M | 601.31K | 1.36M |
| Change in Payables | 368.23K | 395.31K | 777.62K | 0 | 0 | 0 | 0 | 0 | 798.99K | 0 | 0 | 71.51K |
| Cash from Investing | -89.89K | -421.65K | -52.48K | -28.81K | -446.84K | 50.74K | -1.1M | -148.5K | -133.08K | -208.39K | -213.66K | -108.71K |
| Capital Expenditures | -89.89K | -407.78K | -52.48K | -28.81K | -443.44K | 43.57K | -1.08M | -124.28K | -133.08K | -196.05K | -211.65K | -108.71K |
| CapEx % of Revenue | 0.76% | 3.74% | 0.5% | 0.28% | 4.6% | 0.49% | 13.25% | 1.47% | 1.62% | 2.73% | 3.02% | 1.57% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -13.87K | 0 | 0 | -3.4K | 7.17K | -18.57K | -24.22K | 0 | -12.34K | -2.01K | 0 |
| Cash from Financing | -29.22K | -264.91K | 396.33K | -191.96K | -160.81K | -215.72K | 374.45K | -225.15K | -182.12K | -178.35K | 441.28K | -242.82K |
| Debt Issued (Net) | -29.22K | -362.05K | 307.31K | -27.25K | -26.84K | -26.43K | -27.54K | -27.19K | -182.12K | -26.67K | 408.55K | -242.82K |
| Equity Issued (Net) | 0 | 97.14K | 89.03K | -27.54K | 0 | -58.45K | 0 | -38.93K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -27.54K | 0 | -58.45K | 0 | -38.93K | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -137.18K | -133.97K | -130.84K | 401.99K | -159.03K | 0 | -151.68K | 32.73K | 0 |
| Net Change in Cash | -104.44K | 408.19K | 409.3K | -681.12K | -845.11K | 774.64K | -1.65M | -362.32K | -661.92K | 710.06K | -947.23K | -505.46K |
| Free Cash Flow | -31.5K | 686.97K | 12.97K | -489.15K | -680.9K | 983.18K | -2.01M | -112.95K | -479.8K | 900.75K | -1.39M | -256.58K |
| FCF Margin % | -0.27% | 6.31% | 0.12% | -4.8% | -7.07% | 11.12% | -24.54% | -1.34% | -5.85% | 12.53% | -19.8% | -3.7% |
| FCF Growth % | 95.37% | -30.13% | 100.65% | -333.08% | -41.91% | 9.15% | -44.8% | 55.98% | 90.27% | -19.04% | 49.44% | 93.66% |
| FCF per Share | -0.00 | 0.01 | 0.00 | -0.01 | -0.01 | 0.02 | -0.04 | -0.00 | -0.01 | 0.02 | -0.03 | -0.01 |
| FCF Conversion (FCF/Net Income) | -0.02x | -2.25x | -0.08x | 2.23x | 0.20x | -0.60x | 0.58x | -0.01x | 0.18x | -0.15x | 0.86x | 0.06x |
| Interest Paid | 0 | 0 | 0 | 2.18K | 5.38K | 25.92K | 25.52K | 8.2K | 12.3K | 16.06K | 14.61K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |